FORTIS vs LALPATHLAB: Stock Comparison
Head-to-head financial and trading comparison between Fortis Healthcare Limited (FORTIS) and Dr. Lal Path Labs Ltd. (LALPATHLAB) in the Hospitals & Diagnostics sector.
FORTIS
NSE: FORTISLALPATHLAB
NSE: LALPATHLABKey Metrics Comparison Table
| Metric | FORTIS | LALPATHLAB | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹785.00 | ₹2,005.10 | — |
| 1-Year Price Return | -7.41% | +42.74% | LALPATHLAB (50.15% higher) |
| 52-Week High | ₹990.35 | ₹2,005.10 | — |
| 52-Week Low | ₹770.00 | ₹1,367.20 | — |
| 30-Day Annualized Volatility | 27.38% | 16.31% | LALPATHLAB (Steadier) |
| 30-Day Average Daily Volume | 1,490,168 | 298,732 | FORTIS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between FORTIS and LALPATHLAB, which stock gave better returns over the last year?
LALPATHLAB has outperformed FORTIS over the past 12 months with a gain of 42.74% compared to -7.41%.
Which stock is less volatile: FORTIS or LALPATHLAB?
LALPATHLAB demonstrated lower price volatility (16.31% annualized) compared to FORTIS (27.38%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of FORTIS vs LALPATHLAB?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are FORTIS and LALPATHLAB direct sector competitors?
Yes, both companies operate within the Hospitals & Diagnostics sector in India and are actively tracked as sector peers by institutional and retail market participants.